Volume of the adrenal and pituitary glands in depression

Psychoneuroendocrinology
Lars Vedel KessingUlla Knorr

Abstract

Numerous studies have shown that the hypothalamic-pituitary-adrenal (HPA) axis is hyperactive in some depressed patients. It is unclear whether such hyperactivity results in changed volumes of the adrenal glands, pituitary gland and hypothalamus. We systematically reviewed all controlled studies on the adrenal or pituitary glands or hypothalamus volume in unipolar depressive disorder published in PubMed 1966 to December 2009. We identified three studies that investigated the volume of the adrenal glands and eight studies that examined the volume of the pituitary gland, but no studies on hypothalamus were found. Two out of three studies found a statistically significant increase in adrenal volume in patients compared to controls. Four out of eight studies found a statistically significant increase in pituitary volume in patients compared to controls. Different methodological problems were identified such as small population samples, different subtypes of depression and insufficient matching of patients and controls. Due to large heterogeneity of study designs and data, it was futile to make a meta-analysis. It is concluded that it remains unclear whether hyperactivity of the HPA axis results in enlarged adrenal and pituitary gla...Continue Reading

References

May 1, 1992·Archives of General Psychiatry·C B NemeroffN R Dunnick
Feb 11, 1991·The Journal of Clinical Endocrinology and Metabolism·K R KrishnanC B Nemeroff
Sep 1, 1987·The American Journal of Psychiatry·K Dorovini-Zis, A P Zis
Oct 12, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F Holsboer
Aug 28, 2001·Biological Psychiatry·R B SassiJ C Soares
Oct 16, 2002·Journal of Psychosomatic Research·Susan A EversonGeorge A Kaplan
Mar 9, 2004·Journal of Psychiatric Research·Frank P MacMaster, Vivek Kusumakar
Apr 2, 2004·The American Journal of Psychiatry·Stephanie CampbellGlenda M MacQueen
Oct 30, 2004·The American Journal of Psychiatry·Poul Videbech, Barbara Ravnkilde
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carmine M ParianteRobin M Murray
Jul 6, 2005·Ageing Research Reviews·Dick F SwaabPaul J Lucassen
Jun 21, 2006·Journal of Psychopharmacology·Carmine M Pariante
Dec 19, 2006·Life Sciences·Frank P MacMasterDavid R Rosenberg
Feb 7, 2007·Acta Psychiatrica Scandinavica. Supplementum·B J CarrollJ D Veldhuis
Feb 8, 2007·The Journal of Clinical Endocrinology and Metabolism·Sherita Hill GoldenKaren Horton
Jan 18, 2008·Bipolar Disorders·Frank P MacMasterVivek Kusumakar
Jun 25, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cagdas EkerAli Saffet Gonul
Aug 5, 2008·Trends in Neurosciences·Carmine M Pariante, Stafford L Lightman
Feb 26, 2009·Psychiatry Research·Valentina LorenzettiMurat Yücel
Sep 2, 2009·International Journal of Epidemiology·Jennifer B DowdAllison E Aiello

❮ Previous
Next ❯

Citations

Jan 27, 2016·Molecular Psychiatry·M F Rubin de CelisM Ehrhart-Bornstein
Nov 26, 2011·Biological Psychology·Márcio Silveira CorrêaElke Bromberg
Aug 3, 2012·Revista de psiquiatrí́a y salud mental·John Suckling
Sep 22, 2015·Psychological Medicine·C SmartR H McAllister-Williams
Aug 29, 2013·Therapeutic Advances in Psychopharmacology·Paul David SigalasI Nicol Ferrier
Aug 23, 2019·Brain Structure & Function·Chloe AnastassiadisJens C Pruessner
Oct 3, 2021·Metabolic Brain Disease·Priscilla Karla Fernandes LopesRodrigo Ferreira de Moura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here